EGFR and ERBB2 expression was mainly measured by immunohistochemistry methods in primary tumours and CRC metastases (22), whereas ERBB2 and MET expression was measured in colorectal cancer cells in the same population (23). This evidence concerns the gene EGFR and colorectal carcinoma.